Biology subjects

de Vos, P.

Publications and source records attributed to de Vos, P..

2 recordsLinked to original sources

bioRxiv2023

PermaNet(R) Dual, a new deltamethrin-chlorfenapyr mixture net, shows improved efficacy against pyrethroid-resistant Anopheles gambiae sensu lato in southern Benin

Pyrethroid-chlorfenapyr nets have demonstrated improved entomological and epidemiological impact in trials across Africa. This is driving increased demand for this novel net class in malaria endemic countries. PermaNet(R) Dual is a new deltamethrin-chlorfenapyr net developed by Vestergaard Sarl to provide more options to malaria control programmes. We performed an experimental hut trial to evaluate the efficacy of PermaNet(R) Dual against wild, free-flying pyrethroid-resistant Anopheles gambiae sensu lato in Cove, Benin. PermaNet(R) Dual induced superior levels of mosquito mortality compared to a pyrethroid-only net and a pyrethroid-piperonyl butoxide net both when unwashed (77% with PermaNet(R) Dual vs. 23% with PermaNet(R) 2.0 and 56% with PermaNet(R) 3.0, p<0.001) and after 20 standardised washes (75% with PermaNet(R) Dual vs. 14% with PermaNet(R) 2.0 and 30% with PermaNet(R) 3.0, p<0.001). Using a provisional non-inferiority margin defined by the World Health Organisation, PermaNet(R) Dual was also non-inferior to a pyrethroid-chlorfenapyr net that has demonstrated improved public health value (Interceptor(R) G2), for vector mortality (79% vs. 76%, OR=0.854, 95% CIs: 0.703-1.038) but not for blood-feeding protection (35% vs. 26%, OR=1.445, 95% CIs: 1.203-1.735). PermaNet(R) Dual presents an additional option of this highly effective net class for improved control of malaria transmitted by pyrethroid-resistant mosquitoes.

zoology↗

bioRxiv2020

Digestion, fermentation, and pathogen anti-adhesive properties of the hMO-mimic di-fucosyl-β-cyclodextrin

ScopeHuman milk is widely acknowledged as the best food for infants, and that is not just because of nutritional features. Human milk also contains a plethora of bioactive molecules, including a large set of human milk oligosaccharides (hMOs). Especially fucosylated hMOs have received attention for their anti-adhesive effects on pathogens by preventing attachment to the intestinal wall. Because hMOs are generally challenging to produce in sufficient quantities to study and ultimately apply in (medical) infant formula, hMO mimics are interesting compounds to produce and evaluate for their biological effects. Methods and resultsWe investigated the digestion, fermentation, and pathogen anti-adhesive capacity of the novel hMO mimic di-fucosyl-{beta}-cyclodextrin (DF{beta}CD). We establish that DF{beta}CD is not digested by -amylase and also resists fermentation by the microbiota from a 9 month-old infant. In addition, we reveal that DF{beta}CD blocks adhesion of enterotoxigenic E. coli (ETEC) to Caco-2 cells, especially when DF{beta}CD is pre-incubated with ETEC prior to addition to the Caco-2 cells. ConclusionOur results suggests that DF{beta}CD functions through a decoy effect. We expect that our results inspire the generation and biological evaluation of other fucosylated hMOs and mimics, to obtain a comprehensive overview of the anti-adhesive power of fucosylated glycans.

microbiology↗